Market cap
$1.1b
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Reported pre-lease FCF hit an unprecedented NZ$39.4m, but a 34.3% capex cut and a record 55.9 inventory days complicate the read.
Revenue context before the current result.
Operating profit margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$1.1b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
18.1x
Recent market cap compared with trailing earnings.
EPS
0.27
Recent filing-derived earnings per share.
PEG
Not available
Not meaningful without positive comparable earnings growth.
EV/EBITDA
9.67x
Enterprise value compared with recent EBITDA.
P/FCF
20.62x
Market cap compared with recent free cash flow.
P/B
3.5x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
4.2%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY23 vs HY22
Revenue
$367.9m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$45.6m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
$47m
Caveat: metric quality flags apply; use this value with basis context.
Interim dividend per share
12.0c
+4.3% ↑ vs 11.5c
Total assets
$661.5m
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofBGP HY23Result releasedAnnolyse analysis published
What changed
Inventory rose to NZ$113.0m from NZ$101.1m a year earlier, lifting inventory days to 55.9 from 51.4–52.0 across prior comparable halves – a new high in the supplied series.
Revenue grew 2.7% to NZ$367.9m, well below the 22.6% surge in the prior comparable half. Gross margin slipped 86 bps to 45.64%, and operating profit fell to NZ$70.0m. PBT declined 4.1% to NZ$63.4m and NPAT eased 4.0% to NZ$45.6m on an effective tax rate that was essentially unchanged at 28.1%.
Operating cash flow nonetheless rose 3.5% to NZ$47.0m, and with capex cut 34.3% to NZ$7.7m, pre-lease FCF jumped to NZ$39.4m – the highest in the supplied four-period history (mean NZ$14.1m). The interim dividend was lifted to 12.0 cps from 11.5 cps.
What matters
Expectations
The prior comparable was extraordinary (+22.6% revenue, +69.6% NPAT off a pandemic-disrupted base), so the modest declines this half should be read against a stretched baseline rather than against the four-period historical mean. PBT growth of -4.1% sits within the supplied historical range of -27.6% to 70.6%, and PBT margin of 17.2% remains at the upper edge of the 11.0%–18.4% range.
On shape, HY22 contributed only 48.1% of FY22 revenue and 54.0% of FY22 NPAT, so the business is normally second-half weighted on revenue. Annualised current revenue of NZ$735.9m sits modestly below FY22's NZ$744.5m, but the release does not provide a second-half steer, so any view on full-year direction has to come from inventory absorption and margin trajectory rather than disclosed forward work.
Quality of result
The 4.1% PBT decline came alongside a NZ$11.9m working-capital absorption that is well above the supplied historical mean of NZ$0.7m. OCF still grew, but only because the underlying operating result was strong enough to absorb that drag – and pre-lease FCF was further flattered by a 34.3% drop in capex. ROE eased to 15.3% from 16.8%, which is within the historical 9.6%–19.8% range but directionally weaker.
Payout ratio versus pre-lease FCF is suppressed because the source-backed cash-dividend bridge is unavailable.
Unresolved
This briefing cannot assess whether the inventory build reflects supply-chain timing, deliberate range expansion, or weakening sell-through without category-level stock and sales data that the release does not provide.
Chat
Ask follow-up questions about Briscoe Group's HY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
BGP HY July 2022 Financial Statements and Independent Auditors Review Report
HY23 / financial reportBGP HY July 2022 Results Announcement
HY23 / results announcementBGP HY July 2022 Results Commentary
HY23 / results releaseBGP Half Year Results 1 August 2021 Addendum
HY22 / financial reportBGP Half Year Results Announcement 1 August 2021
HY22 / results announcementBGP Half Year Results Announcement 1 August 2021
HY22 / results releaseBGP FY Jan 2022 Financial Statements and Independent Auditor's Report
FY22 / financial reportBGP FY Jan 2022 Results Announcement
FY22 / results announcementBGP FY Jan 2022 Results Commentary
FY22 / results releaseBGP Addresses to Annual Meeting 19 May 2022
HY23 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 58.6%.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 0.1pp.
Revenue growth context
Revenue growth was 2.7% for this reporting period.
ROE and capital efficiency
ROE was 15.3%, -1.5pp versus the prior comparable period.
Get the next Briscoe Group briefing and related NZX reporting-season updates by email.